| Trial name or title | Varenicline and combined Nicotine Replacement Therapy (NRT) for smoking cessation |
| Methods | Randomised cross‐over assignment |
| Participants | Ongoing recruitment: 500 smokers |
| Interventions | Varenicline (VAR): varenicline tablets, placebo patches, and placebo lozenges, nicotine patch + nicotine lozenge group (NPL): placebo tablets, nicotine patches, and nicotine lozenges, tablets, patches, lozenges previously assigned, switch to different active therapy, extra tablet + patch |
| Outcomes | 7‐day PPA at 12 weeks |
| Starting date | May 2015 |
| Contact information | Paul Cinciripini |
| Notes | Updated June 2018 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.